Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
Chen Z, Digiacomo M, Tu Y, Gu Q, Wang S, Yang X, Chu J, Chen Q, Han Y, Chen J, Nesi G, Sestito S, Macchia M, Rapposelli S, Pi R.
Chen Z, et al. Among authors: sestito s.
Eur J Med Chem. 2017 Jan 5;125:784-792. doi: 10.1016/j.ejmech.2016.09.052. Epub 2016 Sep 17.
Eur J Med Chem. 2017.
PMID: 27736684